Sign in

CIK 0000879407 · Large accelerated filer

ARROWHEAD PHARMACEUTICALS, INC.

Sign in to watch
Ticker
ARWR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Sep 30
Incorporated
DE
Entity type
operating
EIN
460408024
Phone
626-696-4702
Business address
177 E COLORADO BLVD, SUITE 700, PASADENA, CA, 91105
Former names
ARROWHEAD RESEARCH CORP, INTERACTIVE GROUP INC, INTERACTIVE INC
  1. 4 Grant or award Director acquired 38,396 shares (grant or award)
  2. 3 Insider Initial Statement of Ownership
  3. 4 Planned sale Director sold 959 shares at $21.00 ($20,139)
  4. 4 Planned sale Chief Discovery/Trans Medicine sold 32,729 shares at an average $19.82 ($648,824)
  5. 4 Planned sale COO and General Counsel sold 37,184 shares at an average $19.80 ($736,059)
  6. 4 Planned sale Chief Financial Officer sold 45,167 shares at an average $19.77 ($893,095)
  7. 4 Planned sale Chief Executive Officer sold 11,520 shares at $19.05 ($219,456)
  8. 4 Planned sale Director sold 2,850 shares at $20.00 ($57,000)
  9. 4 Planned sale Chief Executive Officer sold 12,563 shares at $19.59 ($246,109)
  10. 4 Grant or award Director acquired 16,733 shares (grant or award)
  11. 4 Grant or award Director acquired 16,733 shares (grant or award)
  12. 4 Grant or award Director acquired 16,733 shares (grant or award)
  13. 4 Grant or award Director acquired 16,733 shares (grant or award)
  14. 4 Grant or award Director acquired 16,733 shares (grant or award)
  15. 4 Grant or award Director acquired 16,733 shares (grant or award)
  16. 4 Planned sale Chief Executive Officer sold 26,712 shares at an average $21.24 ($567,486)
  17. 4 Planned sale Director sold 7,495 shares at an average $21.97 ($164,665)
  18. 4 Planned sale Director sold 5,547 shares at an average $21.91 ($121,556)
  19. 4 Planned sale Director sold 8,994 shares at $21.91 ($197,059)
  20. 5 Insider Annual Insider Trading Report

Page 3 of 25 · 497 filings